Evidence map›Paper›PMID 35274124›Full record

ArticleJournal of cell science2022

Piezo1 activation attenuates thrombin-induced blebbing in breast cancer cells.

Paul O'Callaghan, Adam Engberg, Olle Eriksson, Nikos Fatsis-Kavalopoulos, Christina Stelzl, Gonzalo Sanchez, Olof Idevall-Hagren, Johan Kreuger

Open access · hybridAbstract read
In one paragraph

Article in Journal of cell science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Ion Channels in Gliomas-From Molecular Basis to Treatment.International journal of molecular sciences · 2023
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Paul O'CallaghanDepartment of Medical Cell Biology, Uppsala University, 75123 Uppsala, Sweden.ORCID 0000-0003-3117-5367
Adam EngbergDepartment of Medical Cell Biology, Uppsala University, 75123 Uppsala, Sweden.ORCID 0000-0002-6929-142X
Olle ErikssonDepartment of Medical Cell Biology, Uppsala University, 75123 Uppsala, Sweden.ORCID 0000-0002-0284-830X
Nikos Fatsis-KavalopoulosDepartment of Medical Biochemistry and Microbiology, 75123 Uppsala University, Uppsala, Sweden.ORCID 0000-0002-5081-0138
Christina StelzlDepartment of Medical Cell Biology, Uppsala University, 75123 Uppsala, Sweden.ORCID 0000-0002-3957-9190
Gonzalo SanchezDepartment of Medical Cell Biology, Uppsala University, 75123 Uppsala, Sweden.ORCID 0000-0003-4415-1866
Olof Idevall-HagrenDepartment of Medical Cell Biology, Uppsala University, 75123 Uppsala, Sweden.ORCID 0000-0002-0241-6304
Johan KreugerDepartment of Medical Cell Biology, Uppsala University, 75123 Uppsala, Sweden.ORCID 0000-0002-2055-7776
Uppsala University · SE

Funding

Cancerfonden CAN 2017/703Göran Gustafssons StiftelserO.E. och Edla Johanssons Vetenskapliga StiftelseUppsala UniversitetVetenskapsrådet MH2015-03087VINNOVA 2019-00029
6 · The paper itself

Abstract

Cancer cells exploit a variety of migration modes to leave primary tumors and establish metastases, including amoeboid cell migration, which is typically reliant on bleb formation. Here we demonstrate that thrombin induces dynamic blebbing in the MDA-MB-231 breast cancer cell line and confirm that protease-activated receptor 1 (PAR1) activation is sufficient to induce this effect. Cell confinement has been implicated as a driving force in bleb-based migration. Unexpectedly, we found that gentle contact compression, exerted using a custom built 'cell press' to mechanically stimulate cells, reduced thrombin-induced blebbing. Thrombin-induced blebbing was similarly attenuated using the small molecule Yoda1, an agonist of the mechanosensitive Ca2+ channel Piezo1, and this attenuation was impaired in Piezo1-depleted cells. Additionally, Piezo1 activation suppressed thrombin-induced phosphorylation of ezrin, radixin and moesin (ERM) proteins, which are implicated in the blebbing process. Our results provide mechanistic insights into Piezo1 activation as a suppressor of dynamic blebbing, specifically that which is induced by thrombin.

Indexed as

Breast NeoplasmsIon ChannelsCell MovementFemaleHumansPhosphorylationThrombinIon ChannelsPIEZO1 protein, humanThrombinBlebbingBreast cancerPiezo1Thrombin

Identifiers

PMID35274124
PMCPMC9016622
OpenAlexW4220958372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.